← Back to Search

Behavioural Intervention

Remote Patient Management for Cardiac Arrhythmias (RPM CIED Tachy Trial)

N/A
Recruiting
Led By Ratika Parkash, MD FRCPC
Research Sponsored by Ratika Parkash
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights

RPM CIED Tachy Trial Summary

This trial will compare remote patient management to usual care, and will focus on whether or not the RemoteView system is used.

Who is the study for?
This trial is for individuals who can consent and have a specific Medtronic or Abbott defibrillator that supports remote monitoring. They must have a family physician and not be part of another clinical trial. It's not for those needing frequent heart clinic visits or with unreliable pacemaker function.Check my eligibility
What is being tested?
The study compares two approaches to managing cardiac arrhythmias: one group will use remote patient management tools, while the other will receive usual care without these tools. Participants are randomly assigned to groups, considering their current tech use and location.See study design
What are the potential side effects?
Since this trial involves management methods rather than medication, traditional side effects aren't expected. However, there may be risks related to data privacy, reliance on technology for health monitoring, and potential delays in emergency response.

RPM CIED Tachy Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time to a device-detected event
Time to major adverse cardiac event (primary safety outcome)
Secondary outcome measures
Atrial fibrillation related hospitalizations
Cost effectiveness
Detection of atrial fibrillation episodes
+2 more

RPM CIED Tachy Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Remote Patient ManagementActive Control1 Intervention
Patients will be followed by remote monitoring only.
Group II: Standard of CarePlacebo Group1 Intervention
Remote monitoring at 6 month intervals, alternating with yearly in-clinic visits at their usual site.

Find a Location

Who is running the clinical trial?

Ratika ParkashLead Sponsor
4 Previous Clinical Trials
1,251 Total Patients Enrolled
1 Trials studying Arrhythmia
176 Patients Enrolled for Arrhythmia
Cardiac Arrhythmia Network of CanadaOTHER
11 Previous Clinical Trials
5,115 Total Patients Enrolled
1 Trials studying Arrhythmia
176 Patients Enrolled for Arrhythmia
Ratika Parkash, MD FRCPCPrincipal InvestigatorNova Scotia Health Authority
2 Previous Clinical Trials
942 Total Patients Enrolled

Media Library

Remote Patient Management (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03405740 — N/A
Arrhythmia Research Study Groups: Remote Patient Management, Standard of Care
Arrhythmia Clinical Trial 2023: Remote Patient Management Highlights & Side Effects. Trial Name: NCT03405740 — N/A
Remote Patient Management (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03405740 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current number of participants in this experiment?

"Affirmative, clinicaltrials.gov has data to suggest that the medical trial is actively recruiting individuals as of March 10th 2022. The venture was initially announced May 1st 2020 and seeks 2554 participants from 9 distinct sites."

Answered by AI

What are the geographical limits of this scientific experiment?

"This trial has recruited patients from 9 different sites, including London Health Sciences Center in the UK and Hopital SacreCoeur & Hopital Laval in Canada. Additionally, other locations across North America are participating as well."

Answered by AI

Could you explain the fundamental aims of this research project?

"This trial will be evaluated over an 18 month period, with the primary goal of measuring a device-detected event. Additional metrics include Atrial fibrillation related hospitalizations (Hospitalization with a primary diagnosis of atrial fibrillation), Detection of atrial fibrillation episodes (Device detected episodes of atrial fibrillation), and Cost effectiveness (An economic evaluation including cost utility analysis)."

Answered by AI

Is this scientific research currently open to new participants?

"Affirmative. According to the clinical trial data posted on clinicialtrials.gov, this study is currently seeking participants since its initial launch date of May 1st 2020 and most recent edit made March 10th 2022. This medical research requires 2554 volunteers from 9 different sites for successful enrollment."

Answered by AI
~371 spots leftby Dec 2024